Literature DB >> 9175965

Transcranial cytokine gradients in patients requiring intensive care after acute brain injury.

E G McKeating1, P J Andrews, D F Signorini, L Mascia.   

Abstract

After acute brain injury there may be increased intracranial production of cytokines, with activation of inflammatory cascades. We have sought to determine if a transcranial cytokine gradient was demonstrable in paired sera of 32 patients requiring intensive care after acute brain injury. The difference between concentrations of IL-1 beta, IL-6, IL-8 and TNF alpha in jugular venous and arterial serum was measured on admission, and at 24, 48 and 96 h after the primary injury. There were no differences in IL-1 beta, IL-8 or TNF alpha, but median gradients of 6.7 and 11.5 pg ml-1 for IL-6 were demonstrated in the traumatic brain injury (n = 22) and subarachnoid haemorrhage (n = 10) groups, respectively (normal values in serum < 4.7 pg ml-1; P < 0.001 both groups). This suggests that there is significant production of IL-6 by intracranial cells after acute brain injury. Therapy directed towards combatting the negative effects of IL-6 may potentially benefit patients who have sustained an acute brain injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175965     DOI: 10.1093/bja/78.5.520

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  35 in total

Review 1.  [Organ protective intensive care treatment and simulation-based training].

Authors:  J W Rey; T Ott; D Bösebeck; S Welschehold; P R Galle; C Werner
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

Review 2.  Brain-lung crosstalk: Implications for neurocritical care patients.

Authors:  Ségolène Mrozek; Jean-Michel Constantin; Thomas Geeraerts
Journal:  World J Crit Care Med       Date:  2015-08-04

Review 3.  Respiratory mechanics in brain injury: A review.

Authors:  Antonia Koutsoukou; Maria Katsiari; Stylianos E Orfanos; Anastasia Kotanidou; Maria Daganou; Magdalini Kyriakopoulou; Nikolaos G Koulouris; Nikoletta Rovina
Journal:  World J Crit Care Med       Date:  2016-02-04

4.  Ventilatory setting in severe brain injured patients: does it really matter?

Authors:  Luciana Mascia
Journal:  Intensive Care Med       Date:  2006-10-20       Impact factor: 17.440

Review 5.  What has inflammation to do with traumatic brain injury?

Authors:  David Cederberg; Peter Siesjö
Journal:  Childs Nerv Syst       Date:  2009-11-26       Impact factor: 1.475

6.  Multivariate projection method to investigate inflammation associated with secondary insults and outcome after human traumatic brain injury: a pilot study.

Authors:  Anna Teresa Mazzeo; Claudia Filippini; Rosalba Rosato; Vito Fanelli; Barbara Assenzio; Ian Piper; Timothy Howells; Ilaria Mastromauro; Maurizio Berardino; Alessandro Ducati; Luciana Mascia
Journal:  J Neuroinflammation       Date:  2016-06-21       Impact factor: 8.322

Review 7.  Progesterone and vitamin d hormone as a biologic treatment of traumatic brain injury in the aged.

Authors:  Donald G Stein; Milos M Cekic
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

Review 8.  Hypopituitarism and growth hormone deficiency in adult subjects after traumatic brain injury: who and when to test.

Authors:  Monica Lorenzo; Roberto Peino; Ana I Castro; Mary Lage; Vera Popovic; Carlos Dieguez; Felipe F Casanueva
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

9.  Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury.

Authors:  Hideki Yasui; Deborah L Donahue; Mark Walsh; Francis J Castellino; Victoria A Ploplis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-17       Impact factor: 5.464

10.  Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients.

Authors:  Jun Oto; Atsuhiko Suzue; Daisuke Inui; Yasushi Fukuta; Kikumi Hosotsubo; Mayumi Torii; Shinji Nagahiro; Masaji Nishimura
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.